Corbevax by September end in India, said sources on Monday. Sources told ANI that the company has started its phase 3 clinical trials.
Biological E's COVID-19 vaccine Corbevax has been booked by the government before preclinical stage phase 3 studies. In the latest written reply, Union Minister of State for Health, Dr Bharati Pravin Pawar said that the Government of India has also provided financial assistance to domestic vaccine manufacturer Biological E which is currently in advance phase 3 clinical trials for 'at-risk manufacturing' of the COVID-19 vaccine.
Biological E is expected to apply for an Emergency use License (EUL) by August end and will be supplying 300 million doses to the Government of India by December 2021.